The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

Hepatitis B and C (HBV/HCV) coinfected patients have a potential risk of hepatitis B reactivation (HBVr) after direct-acting antivirals (DAAs) treatment. The study intends to investigate the predictive role of HBV biomarkers in HBVr. Forty-six HBV/HCV coinfected patients receiving DAAs were enrolled...

Full description

Bibliographic Details
Main Authors: Chih-Wei Tseng, Wen-Chun Liu, Ping-Hung Ko, Yen-Chun Chen, Kuo-Chih Tseng, Ting-Tsung Chang
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Viruses
Subjects:
hepatitis B surface antigen
hepatitis B core-related antigen
HBV pregenomic RNA
hepatitis C
HBV/HCV coinfection
direct-acting antiviral
Online Access:https://www.mdpi.com/1999-4915/14/8/1812

Internet

https://www.mdpi.com/1999-4915/14/8/1812

Similar Items